US 8513197
Ganglioside epitopes for treating Guillain-Barre syndrome
granted A61KA61K2039/505A61K38/00
Quick answer
US patent 8513197 (Ganglioside epitopes for treating Guillain-Barre syndrome) held by Georgia Regents University expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Georgia Regents University
- Grant date
- Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K2039/505, A61K38/00, A61P, A61P25/00